Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.5640 USD
−17.31 M USD
0.00 USD
8.97 M
About Enveric Biosciences, Inc.
Sector
CEO
Joseph Tucker
Headquarters
Naples
Website
Founded
1994
FIGI
BBG000BBQ281
Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company was founded on February 28, 1994 and is headquartered in Naples, FL.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ENVB is 0.3369 USD — it has decreased by −1.44% in the past 24 hours. Watch Enveric Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Enveric Biosciences, Inc. stocks are traded under the ticker ENVB.
ENVB stock has fallen by −20.86% compared to the previous week, the month change is a −25.07% fall, over the last year Enveric Biosciences, Inc. has showed a −76.60% decrease.
ENVB reached its all-time high on Sep 15, 1995 with the price of 5,503,125.0000 USD, and its all-time low was 0.3564 USD and was reached on Nov 15, 2024. View more price dynamics on ENVB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ENVB stock is 14.68% volatile and has beta coefficient of −0.01. Track Enveric Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Enveric Biosciences, Inc. there?
Today Enveric Biosciences, Inc. has the market capitalization of 3.48 M, it has decreased by −11.86% over the last week.
Yes, you can track Enveric Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Enveric Biosciences, Inc. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
ENVB earnings for the last quarter are −0.24 USD per share, whereas the estimation was −0.52 USD resulting in a 53.85% surprise. The estimated earnings for the next quarter are −0.40 USD per share. See more details about Enveric Biosciences, Inc. earnings.
ENVB net income for the last quarter is −2.08 M USD, while the quarter before that showed −1.88 M USD of net income which accounts for −10.89% change. Track more Enveric Biosciences, Inc. financial stats to get the full picture.
No, ENVB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 7.00 employees. See our rating of the largest employees — is Enveric Biosciences, Inc. on this list?
Like other stocks, ENVB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enveric Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Enveric Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Enveric Biosciences, Inc. stock shows the sell signal. See more of Enveric Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.